Correlation Between Ascendis Pharma and Plano Plano

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Plano Plano at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Plano Plano into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and Plano Plano Desenvolvimento, you can compare the effects of market volatilities on Ascendis Pharma and Plano Plano and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Plano Plano. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Plano Plano.

Diversification Opportunities for Ascendis Pharma and Plano Plano

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Ascendis and Plano is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Plano Plano Desenvolvimento in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Plano Plano Desenvol and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Plano Plano. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Plano Plano Desenvol has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Plano Plano go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Plano Plano

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 0.52 times more return on investment than Plano Plano. However, Ascendis Pharma AS is 1.91 times less risky than Plano Plano. It trades about 0.31 of its potential returns per unit of risk. Plano Plano Desenvolvimento is currently generating about -0.16 per unit of risk. If you would invest  5,335  in Ascendis Pharma AS on October 20, 2024 and sell it today you would earn a total of  509.00  from holding Ascendis Pharma AS or generate 9.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ascendis Pharma AS  vs.  Plano Plano Desenvolvimento

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ascendis Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Plano Plano Desenvol 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Plano Plano Desenvolvimento has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Ascendis Pharma and Plano Plano Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and Plano Plano

The main advantage of trading using opposite Ascendis Pharma and Plano Plano positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Plano Plano can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Plano Plano will offset losses from the drop in Plano Plano's long position.
The idea behind Ascendis Pharma AS and Plano Plano Desenvolvimento pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities